Title of the article, "breakthrough cancer treatments help death rates fall." Geron stock price $2.05. Volumes only 204,500 shares. Still no word of the earnings. Thinking Chip will have good news on Feb 28th. This will be a make or break year for Geron. With six phase 2 trials, 4 are ending in December of this year. If results are good to Geron go to $10. If results are bad Geron goes to pennies.
ACTC is up at 0.115 on light volume. If they can get good results on their phase 2 trials making the blind see stock should go up to a dollar.
Always remember you can lose all your money on any stock.
Good luck in this rigged casino,
No comments:
Post a Comment